An2 Therapeutics, INC. (ANTX) SEC Filings — 2026
7 SEC filings for An2 Therapeutics, INC. (ANTX) in 2026.
Filings
- AN2 Therapeutics SEC Filing Effectiveness Notice — EFFECT · Apr 21, 2026
- An2 Therapeutics, INC. 8-K Filing — 8-K · Apr 9, 2026
- AN2 Therapeutics: Incomplete Form 4 Filed for Sanjay Chanda — 4 · Mar 23, 2026
- AN2 Therapeutics: Form 4 Filed for Margaret M. FitzPatrick — 4 · Mar 23, 2026
- AN2 Therapeutics: Insider Stephanie Wong Files Form 4 — 4 · Mar 23, 2026
- AN2 Therapeutics: Insider Ownership Change Filed, Details Pending — 4 · Mar 23, 2026
- AN2 Therapeutics: Melvin K. Spigelman Files Form 4 — 4 · Mar 23, 2026